These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28551823)

  • 1. Indirect comparisons of the efficacy of biological agents in patients with active ankylosing spondylitis: a systematic review and meta-analysis.
    Ungprasert P; Erwin PJ; Koster MJ
    Clin Rheumatol; 2017 Jul; 36(7):1569-1577. PubMed ID: 28551823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indirect comparisons of the efficacy of biological agents in patients with psoriatic arthritis with an inadequate response to traditional disease-modifying anti-rheumatic drugs or to non-steroidal anti-inflammatory drugs: A meta-analysis.
    Ungprasert P; Thongprayoon C; Davis JM
    Semin Arthritis Rheum; 2016 Feb; 45(4):428-38. PubMed ID: 26610638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indirect comparisons of the efficacy of subsequent biological agents in patients with psoriatic arthritis with an inadequate response to tumor necrosis factor inhibitors: a meta-analysis.
    Ungprasert P; Thongprayoon C; Davis JM
    Clin Rheumatol; 2016 Jul; 35(7):1795-803. PubMed ID: 26852316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Efficacy and Safety of Janus Kinase Inhibitors and Secukinumab in Patients with Active Ankylosing Spondylitis: A Systematic Review and Meta-Analysis.
    Lee YH
    Pharmacology; 2022; 107(11-12):537-544. PubMed ID: 35817017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect comparison between subcutaneous biologic agents in ankylosing spondylitis.
    Migliore A; Bizzi E; Bernardi M; Picchianti Diamanti A; Laganà B; Petrella L
    Clin Drug Investig; 2015 Jan; 35(1):23-9. PubMed ID: 25388909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect comparison of the effects of anti-TNF biological agents in patients with ankylosing spondylitis by means of a mixed treatment comparison performed on efficacy data from published randomised, controlled trials.
    Migliore A; Broccoli S; Bizzi E; Laganà B
    J Med Econ; 2012; 15(3):473-80. PubMed ID: 22335398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of serious infections in biological treatment of patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
    Wang S; He Q; Shuai Z
    Clin Rheumatol; 2018 Feb; 37(2):439-450. PubMed ID: 29290076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Janus kinase inhibitors for treating active ankylosing spondylitis: a meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Z Rheumatol; 2022 Feb; 81(1):71-76. PubMed ID: 33340056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment of ankylosing spondylitis: a systematic review.
    Boulos P; Dougados M; Macleod SM; Hunsche E
    Drugs; 2005; 65(15):2111-27. PubMed ID: 16225367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Biologic Therapy Regimens for Ankylosing Spondylitis: A Systematic Review and a Network Meta-Analysis.
    Chen C; Zhang X; Xiao L; Zhang X; Ma X
    Medicine (Baltimore); 2016 Mar; 95(11):e3060. PubMed ID: 26986130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Comparative Safety of TNF Inhibitors in Ankylosing Spondylitis-a Meta-Analysis Update of 14 Randomized Controlled Trials.
    Hou LQ; Jiang GX; Chen YF; Yang XM; Meng L; Xue M; Liu XG; Chen XC; Li X
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):234-243. PubMed ID: 28717941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Benucci M; Gobbi FL; Guiducci S; Foti R; Mosca M; Goletti D
    Semin Arthritis Rheum; 2017 Oct; 47(2):183-192. PubMed ID: 28413099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis: a systematic review and network meta-analysis.
    Kawalec P; Holko P; Moćko P; Pilc A
    Rheumatol Int; 2018 Feb; 38(2):189-201. PubMed ID: 29285605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
    Brandt J; Listing J; Haibel H; Sörensen H; Schwebig A; Rudwaleit M; Sieper J; Braun J
    Rheumatology (Oxford); 2005 Mar; 44(3):342-8. PubMed ID: 15561737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the short-term efficacy of NSAIDs on patients with active ankylosing spondylitis in daily practice: a 3-month, longitudinal, observational study.
    Cinar M; Dinc A; Simsek I; Erdem H; Koc B; Pay S; Kilic S
    Rheumatol Int; 2010 Jan; 30(3):331-40. PubMed ID: 19466421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and network meta-analysis of current and investigational treatments for active ankylosing spondylitis.
    Deodhar A; Chakravarty SD; Cameron C; Peterson S; Hensman R; Fogarty S; Spin P; Kafka S; Nair S; Gensler LS
    Clin Rheumatol; 2020 Aug; 39(8):2307-2315. PubMed ID: 32107666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis.
    Yin Y; Wang M; Liu M; Zhou E; Ren T; Chang X; He M; Zeng K; Guo Y; Wu J
    Arthritis Res Ther; 2020 May; 22(1):111. PubMed ID: 32398096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indirect comparison of anti-TNF-α agents for active ankylosing spondylitis: mixed treatment comparison of randomized controlled trials.
    Shu T; Chen GH; Rong L; Feng F; Yang B; Chen R; Wang J
    Clin Exp Rheumatol; 2013; 31(5):717-22. PubMed ID: 23899710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the treatment effect of NSAIDs/TNF blockers according to different domains in ankylosing spondylitis: results of a meta-analysis.
    Escalas C; Trijau S; Dougados M
    Rheumatology (Oxford); 2010 Jul; 49(7):1317-25. PubMed ID: 20360041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of tripterygium glycosides tablet in treating ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials.
    Li H; Guo F; Luo YC; Zhu JP; Wang JL
    Clin Rheumatol; 2015 Nov; 34(11):1831-8. PubMed ID: 26255190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.